Evidence map›Paper›PMID 32767177›Full record

Observational studyEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Irrelevance of Panton-Valentine leukocidin in hidradenitis suppurativa: results from a pilot, observational study.

Monica Corazza, Alessandro Borghi, Vincenzo Bettoli, Roberto Pora, Ilaria Bononi, Elisa Mazzoni, Elisa Mazzola, Silva Saraceni, Martina Maritati, Carlo Contini

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Monica CorazzaSection of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Via L. Ariosto 35, 44121, Ferrara, Italy.
Alessandro BorghiSection of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Via L. Ariosto 35, 44121, Ferrara, Italy. alessandro.borghi@unife.it.ORCID https://orcid.org/0000-0001-9163-9691
Vincenzo BettoliSection of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Via L. Ariosto 35, 44121, Ferrara, Italy.
Roberto PoraAnalysis Laboratory, S. Anna University Hospital, Ferrara, Italy.
Ilaria BononiLaboratories of Cell Biology and Molecular Genetics, Section of Pathology, Oncology and Experimental Biology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Elisa MazzoniLaboratories of Cell Biology and Molecular Genetics, Section of Pathology, Oncology and Experimental Biology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Elisa Mazzola, Palermo, Italy.
Silva SaraceniSection of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Via L. Ariosto 35, 44121, Ferrara, Italy.
Martina MaritatiSection of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Via L. Ariosto 35, 44121, Ferrara, Italy.
Carlo ContiniSection of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Via L. Ariosto 35, 44121, Ferrara, Italy.
University of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Panton-Valentine leukocidin (PVL) appears to be a virulence factor which, among others, can exacerbate the pathogenicity of Staphylococcus aureus infections, especially inducing severe necrotic, deep-seated skin infections, abscesses, and recurrences. These peculiarities have some overlaps with hidradenitis suppurativa (HS). Our main aim was to assess if S. aureus producing PVL could have some role in influencing clinical features and/or course of HS, specifically in the suppuration and recurrence of lesions. This pilot, mono-centric, observational study included all adult subjects affected with HS consecutively referring to our HS clinic over a 3-month period. Clinically evident suppuration and at least 2 weeks wash out from any antibiotic were the main inclusion criteria. Purulent material from HS skin lesions was collected with swabs in order to isolate micro-organisms, with specific regard to S. aureus. Detection of PVL was performed by real-time quantitative PCR (RT-qPCR). We also analyzed purulent material from suppurative skin lesions other than HS, as a control. Thirty HS patients were included; 29 purulent lesions (96.7%) harbored at least one bacterial species. Five (16.7%) swab samples were positive for S. aureus, none of which was positive for PVL genes. Among the 30 purulent disorders included as controls, 8 (26.3%) were positive for S. aureus; of these, 4 strains (50%) expressed LPV. The study results seem to exclude the pathogenetic involvement of S. aureus producing PVL in HS; as a result, PVL does not seem to represent a potential target in the future development of HS treatments.

Indexed as

AdultBacterial ToxinsExotoxinsFemaleHidradenitis SuppurativaHumansLeukocidinsMalePilot ProjectsReal-Time Polymerase Chain ReactionStaphylococcus aureusBacterial ToxinsExotoxinsLeukocidinsPanton-Valentine leukocidinHidradenitis suppurativaInfectionsPanton-Valentine leukocidinRT-qPCRStaphylococcus aureus

Identifiers

PMID32767177
PMCPMC7782376
OpenAlexW3048265439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.